Researcher discovers new 'anti-pathogenic' drugs to treat MRSA
Thursday, September 16, 2010 - 15:14
in Health & Medicine
Menachem Shoham, PhD, associate professor and researcher in the department of biochemistry at the Case Western Reserve University School of Medicine, has identified new anti-pathogenic drugs that, without killing the bacteria, render Methicillin Resistant Staphylococcus Aureus (MRSA) harmless by preventing the production of toxins that cause disease.